TOL
TOLRESTAT
Created: | 1999-07-08 |
Last modified: | 2011-06-04 |
Find Related PDB Entry |
---|
Find related ligands: |
---|
Chemical Details | |
---|---|
Formal Charge | 0 |
Atom Count | 38 |
Chiral Atom Count | 0 |
Bond Count | 39 |
Aromatic Bond Count | 11 |
Chemical Component Summary | |
---|---|
Name | TOLRESTAT |
Systematic Name (OpenEye OEToolkits) | 2-[[6-methoxy-5-(trifluoromethyl)naphthalen-1-yl]carbothioyl-methyl-amino]ethanoic acid |
Formula | C16 H14 F3 N O3 S |
Molecular Weight | 357.347 |
Type | NON-POLYMER |
Chemical Descriptors | |||
---|---|---|---|
Type | Program | Version | Descriptor |
SMILES | ACDLabs | 10.04 | O=C(O)CN(C(=S)c2c1ccc(OC)c(c1ccc2)C(F)(F)F)C |
SMILES | CACTVS | 3.341 | COc1ccc2c(cccc2c1C(F)(F)F)C(=S)N(C)CC(O)=O |
SMILES | OpenEye OEToolkits | 1.5.0 | CN(CC(=O)O)C(=S)c1cccc2c1ccc(c2C(F)(F)F)OC |
Canonical SMILES | CACTVS | 3.341 | COc1ccc2c(cccc2c1C(F)(F)F)C(=S)N(C)CC(O)=O |
Canonical SMILES | OpenEye OEToolkits | 1.5.0 | CN(CC(=O)O)C(=S)c1cccc2c1ccc(c2C(F)(F)F)OC |
InChI | InChI | 1.03 | InChI=1S/C16H14F3NO3S/c1-20(8-13(21)22)15(24)11-5-3-4-10-9(11)6-7-12(23-2)14(10)16(17,18)19/h3-7H,8H2,1-2H3,(H,21,22) |
InChIKey | InChI | 1.03 | LUBHDINQXIHVLS-UHFFFAOYSA-N |
Drug Info: DrugBank
DrugBank ID | DB02383 |
---|---|
Name | Tolrestat |
Groups | withdrawn |
Description | Tolrestat (INN) (AY-27773) is an aldose reductase inhibitor which was approved for the control of certain diabetic complications. While it was approved for marketed in several countries, it failed a Phase III trial in the U.S. due to toxicity and never received FDA approval. It was sold under the tradename Alredase but was discontinued by Wyeth in 1997 because of the risk of severe liver toxicity and death. |
Synonyms | Tolrestat |
Indication | For the pharmacological control of certain diabetic complications. |
Categories |
|
ATC-Code | A10XA01 |
CAS number | 82964-04-3 |
Drug Targets
Name | Target Sequence | Pharmacological Action | Actions |
---|---|---|---|
Alcohol dehydrogenase [NADP(+)] | MAASCVLLHTGQKMPLIGLGTWKSEPGQVKAAVKYALSVGYRHIDCAAIY... | unknown | |
Aldo-keto reductase family 1 member B10 | MATFVELSTKAKMPIVGLGTWKSPLGKVKEAVKVAIDAGYRHIDCAYVYQ... | unknown | |
Aldose reductase | MASRLLLNNGAKMPILGLGTWKSPPGQVTEAVKVAIDVGYRHIDCAHVYQ... | unknown | inhibitor |
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682
Related Resource References
Resource Name | Reference |
---|---|
Pharos | CHEMBL436 |
PubChem | 53359 |
ChEMBL | CHEMBL436 |
ChEBI | CHEBI:48549 |